CVE-2015-3957

mediumPriorität · verfolgen · 18OT-Risiko · erhöhtEPSS 0.005 · 45. PerzentilEURUUS
grimoire priorityP3 · Track
Exploitable?
—
no known exploitation
Likely / severe?
0.54% (45th) EPSS
CVSS 4.6 · medium
Is it mine?
13 products
Prüfe deine Angriffsfläche
Who says so?
5 sources
cnnvd · enisa_euvd · fstec_bdu · cisa_csaf_ot

EPSS · bewertet 2026-10-22

Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.

01

Behebungen

Hersteller-Fix, Mitigation oder Workaround, wie von den Quellen veröffentlicht.

Noch kein Hersteller-Fix; eine Mitigation ist verfügbar.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.

  • MitigationPlum A+ Infusion Systemcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion Systemcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closedcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

02

cvss

Technischer Schweregrad, 0–10. Eine Zeile je Quelle.

4.6
010

Basiswert 0–10 · höher = schwerwiegender · Vektor überfahren zum Auflösen⚠ Quellen uneinig · low–medium · 3.9–4.6

v2.04.6mediumAV:L/AC:L/Au:N/C:P/I:P/A:Pprimary · NVD / NIST USAusnutzbarkeit 3.9 · Auswirkung 6.4
v2.04.6mediumAV:L/AC:L/Au:N/C:P/I:P/A:Psecondary · CISA US
v2.04.6mediumAV:L/AC:L/Au:N/C:P/I:P/A:Psecondary · FSTEC (BDU) RU
v2.03.9lowAV:L/AC:L/Au:N/C:P/I:P/A:P/E:Usecondary · CVSS-BT (t0sche)
03

schwächen

Die CWE-Schwächeklassen, zu denen dies gehört.

04

betroffene Produkte (13)

Betroffene Produkte und Versionsbereiche.

05

Advisories (2)

Hersteller- und Ökosystem-Meldungen dazu.

  • ICSA-15-125-01BHospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

  • ICSA-15-161-01Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities2015-03-13icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

06

auch bekannt als (4)

Weitere Namen und Kennungen dieser Entität.

07

quellen

Welche Quellen diesen Datensatz belegen und wann.

veröffentlicht 2015-07-06geändert 2026-06-17
09

Referenzen (10)

Externe Belege — Patches, Meldungen, Analysen.

scry

Angreifer nutzen Schwachstellen wie diese gegen im Internet exponierte Dienste aus. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.

Kostenloser Scan